Stock Analysis on Net
Stock Analysis on Net

Shockwave Medical Inc. (NASDAQ:SWAV)

This company has been moved to the archive! The financial data has not been updated since May 6, 2024.

Analysis of Revenues 

Microsoft Excel

Revenues as Reported

Shockwave Medical Inc., income statement, revenues

US$ in thousands

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Coronary 528,845 353,859 161,463 24,586 15,621
Peripheral 194,346 132,284 74,064 41,994 26,325
Reducer 4,368 — — — —
Other 2,671 3,590 1,619 1,209 981
Product revenue 730,230 489,733 237,146 67,789 42,927

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Item Description The company
Product revenue Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Shockwave Medical Inc. product revenue increased from 2021 to 2022 and from 2022 to 2023.